Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy.
- Resource Type
- Article
- Source
- BMC Medicine; 1/8/2024, Vol. 22 Issue 1, p1-20, 20p
- Subject
ARRHYTHMOGENIC right ventricular dysplasia RNA sequencing HEART failure patients ARRHYTHMIA NLRP3 protein MYELOID differentiation factor 88 - Language
- ISSN
- 17417015